Cargando…

External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes

AIMS/HYPOTHESIS: Treatment guidelines recommend the UK Prospective Diabetes Study (UKPDS) risk engine for predicting cardiovascular risk in patients with type 2 diabetes, although validation studies showed moderate performance. The methods used in these validation studies were diverse, however, and...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dieren, S., Peelen, L. M., Nöthlings, U., van der Schouw, Y. T., Rutten, G. E. H. M., Spijkerman, A. M. W., van der A, D. L., Sluik, D., Boeing, H., Moons, K. G. M., Beulens, J. W. J.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017299/
https://www.ncbi.nlm.nih.gov/pubmed/21076956
http://dx.doi.org/10.1007/s00125-010-1960-0
_version_ 1782195892041809920
author van Dieren, S.
Peelen, L. M.
Nöthlings, U.
van der Schouw, Y. T.
Rutten, G. E. H. M.
Spijkerman, A. M. W.
van der A, D. L.
Sluik, D.
Boeing, H.
Moons, K. G. M.
Beulens, J. W. J.
author_facet van Dieren, S.
Peelen, L. M.
Nöthlings, U.
van der Schouw, Y. T.
Rutten, G. E. H. M.
Spijkerman, A. M. W.
van der A, D. L.
Sluik, D.
Boeing, H.
Moons, K. G. M.
Beulens, J. W. J.
author_sort van Dieren, S.
collection PubMed
description AIMS/HYPOTHESIS: Treatment guidelines recommend the UK Prospective Diabetes Study (UKPDS) risk engine for predicting cardiovascular risk in patients with type 2 diabetes, although validation studies showed moderate performance. The methods used in these validation studies were diverse, however, and sometimes insufficient. Hence, we assessed the discrimination and calibration of the UKPDS risk engine to predict 4, 5, 6 and 8 year cardiovascular risk in patients with type 2 diabetes. METHODS: The cohort included 1,622 patients with type 2 diabetes. During a mean follow-up of 8 years, patients were followed for incidence of CHD and cardiovascular disease (CVD). Discrimination and calibration were assessed for 4, 5, 6 and 8 year risk. Discrimination was examined using the c-statistic and calibration by visually inspecting calibration plots and calculating the Hosmer–Lemeshow χ(2) statistic. RESULTS: The UKPDS risk engine showed moderate to poor discrimination for both CHD and CVD (c-statistic of 0.66 for both 5 year CHD and CVD risks), and an overestimation of the risk (224% and 112%). The calibration of the UKPDS risk engine was slightly better for patients with type 2 diabetes who had been diagnosed with diabetes more than 10 years ago compared with patients diagnosed more recently, particularly for 4 and 5 year predicted CVD and CHD risks. Discrimination for these periods was still moderate to poor. CONCLUSIONS/INTERPRETATION: We observed that the UKPDS risk engine overestimates CHD and CVD risk. The discriminative ability of this model is moderate, irrespective of various subgroup analyses. To enhance the prediction of CVD in patients with type 2 diabetes, this model should be updated. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-010-1960-0) contains supplementary material, which is available to authorised users.
format Text
id pubmed-3017299
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-30172992011-02-04 External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes van Dieren, S. Peelen, L. M. Nöthlings, U. van der Schouw, Y. T. Rutten, G. E. H. M. Spijkerman, A. M. W. van der A, D. L. Sluik, D. Boeing, H. Moons, K. G. M. Beulens, J. W. J. Diabetologia Article AIMS/HYPOTHESIS: Treatment guidelines recommend the UK Prospective Diabetes Study (UKPDS) risk engine for predicting cardiovascular risk in patients with type 2 diabetes, although validation studies showed moderate performance. The methods used in these validation studies were diverse, however, and sometimes insufficient. Hence, we assessed the discrimination and calibration of the UKPDS risk engine to predict 4, 5, 6 and 8 year cardiovascular risk in patients with type 2 diabetes. METHODS: The cohort included 1,622 patients with type 2 diabetes. During a mean follow-up of 8 years, patients were followed for incidence of CHD and cardiovascular disease (CVD). Discrimination and calibration were assessed for 4, 5, 6 and 8 year risk. Discrimination was examined using the c-statistic and calibration by visually inspecting calibration plots and calculating the Hosmer–Lemeshow χ(2) statistic. RESULTS: The UKPDS risk engine showed moderate to poor discrimination for both CHD and CVD (c-statistic of 0.66 for both 5 year CHD and CVD risks), and an overestimation of the risk (224% and 112%). The calibration of the UKPDS risk engine was slightly better for patients with type 2 diabetes who had been diagnosed with diabetes more than 10 years ago compared with patients diagnosed more recently, particularly for 4 and 5 year predicted CVD and CHD risks. Discrimination for these periods was still moderate to poor. CONCLUSIONS/INTERPRETATION: We observed that the UKPDS risk engine overestimates CHD and CVD risk. The discriminative ability of this model is moderate, irrespective of various subgroup analyses. To enhance the prediction of CVD in patients with type 2 diabetes, this model should be updated. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-010-1960-0) contains supplementary material, which is available to authorised users. Springer-Verlag 2010-11-14 2011 /pmc/articles/PMC3017299/ /pubmed/21076956 http://dx.doi.org/10.1007/s00125-010-1960-0 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
van Dieren, S.
Peelen, L. M.
Nöthlings, U.
van der Schouw, Y. T.
Rutten, G. E. H. M.
Spijkerman, A. M. W.
van der A, D. L.
Sluik, D.
Boeing, H.
Moons, K. G. M.
Beulens, J. W. J.
External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
title External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
title_full External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
title_fullStr External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
title_full_unstemmed External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
title_short External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
title_sort external validation of the uk prospective diabetes study (ukpds) risk engine in patients with type 2 diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017299/
https://www.ncbi.nlm.nih.gov/pubmed/21076956
http://dx.doi.org/10.1007/s00125-010-1960-0
work_keys_str_mv AT vandierens externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes
AT peelenlm externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes
AT nothlingsu externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes
AT vanderschouwyt externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes
AT ruttengehm externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes
AT spijkermanamw externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes
AT vanderadl externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes
AT sluikd externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes
AT boeingh externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes
AT moonskgm externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes
AT beulensjwj externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes